Invention Grant
US08722712B2 Substituted aryl 1 ,2,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
失效
取代的芳基1,2,4-恶二唑衍生物作为鞘氨醇-1磷酸受体调节剂
- Patent Title: Substituted aryl 1 ,2,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
- Patent Title (中): 取代的芳基1,2,4-恶二唑衍生物作为鞘氨醇-1磷酸受体调节剂
-
Application No.: US14041539Application Date: 2013-09-30
-
Publication No.: US08722712B2Publication Date: 2014-05-13
- Inventor: Janet A. Takeuchi , Ling Li , Wha-Bin Im , Ken Chow
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D271/06
Abstract:
The present invention relates to substituted aryl 1,2,4-oxadiazoles derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20140100199A1 SUBSTITUTED ARYL 1 ,2,4-OXADIAZOLES DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS Public/Granted day:2014-04-10
Information query
